FDA Commissioner Marks 100 Days of Focused Reforms for a Healthier America
Marty Makary, the new FDA commissioner, has made a series of bold announcements and media appearances in his first 100 days, including a proposal to make public the complete response letters sent to companies regarding drug approvals. While this could lead to positive changes, there are concerns that some of his initiatives may overlook the FDA's traditional methods and risk undermining its effective functioning, with uncertain outcomes.